GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Jagsonpal Pharmaceuticals Ltd

Jagsonpal Pharmaceuticals Appoints 2 Senior Management Personnel Effective July 29, 2026

MANAGEMENT ▲ Positive Development LOW RISK
📅 Filed on BSE: 29 Jul 2026, 06:45 PM IST  ·  BSE ID: 93c6865c-6a26-4d2c-927a-2204f20ecf60
View Original BSE Filing (PDF)
💡
In Simple Terms
Jagsonpal Pharmaceuticals has promoted two managers to senior roles in IT and regulatory affairs as part of its internal reorganization.
🤖 AI Summary
  • Jagsonpal Pharmaceuticals designated two individuals as Senior Management Personnel.
  • Mr. Balmukund Keshav appointed Deputy General Manager - Information Technology.
  • Mr. Sanjay Singhal appointed General Manager - CQA & Regulatory Affairs.
  • Designations are effective July 29, 2026, following internal restructuring.
🏢 How This Affects the Company
📈
Business Impact
This appointment signifies a structured approach to departmental leadership within the company, focusing on critical functions like IT and regulatory compliance.
⚙️
Operational Impact
The company has formally recognized key personnel in Information Technology and Quality Assurance & Regulatory Affairs, indicating a strengthening of these operational areas.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders.
👤
Who Is Affected
All shareholders are affected by management changes that impact company operations and governance.
🔍
Management Signal
This decision signals management's focus on strengthening departmental leadership and operational structures.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Observe impact on departmental efficiency and performance metrics.
Monitor future disclosures regarding management team.
Review upcoming financial results for operational trends.
LOW RISK Routine management change disclosure; no immediate financial or operational risks identified.
💡 Investor Takeaway
Jagsonpal Pharmaceuticals has appointed Mr. Balmukund Keshav and Mr. Sanjay Singhal to senior management roles effective July 29, 2026, as part of internal restructuring.
❓ Frequently Asked Questions
Who has been appointed to senior management at Jagsonpal Pharmaceuticals?
Mr. Balmukund Keshav was appointed Deputy General Manager - Information Technology, and Mr. Sanjay Singhal was appointed General Manager - CQA & Regulatory Affairs.
When are these senior management changes effective at Jagsonpal Pharmaceuticals?
The designations of Mr. Balmukund Keshav and Mr. Sanjay Singhal as Senior Management Personnel are effective July 29, 2026.
Why has Jagsonpal Pharmaceuticals made these management changes?
These appointments are consequent to internal restructuring within the company.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.